Drug · DIN 02540223
HALOPERIDOL INJECTION
FOR I.M. INJECTION ONLY. NOT FOR I.V USE.
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 29, 2026.
- Drug Identification Number (DIN)
- 02540223
- Company (DIN owner)
- Juno Pharmaceuticals Corp.Mississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Haloperidol N05AD01
- Class
- Human
- Record last updated
- August 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HALOPERIDOL | 5 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 4, 2023: NOC 31375Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
Other DINs named HALOPERIDOL INJECTION
- DIN 02366010 · Marketed
- DIN 02493993 · Cancelled (Unreturned Annual)